Sage Journals: Discover world-class research

Retricted access

Review article

First published 2015-5

Empagliflozin,an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

John R. White

Annals of Pharmacotherapy

Free access

Research article

First published 2014-11

Nonclinical Safety of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin

Matthew S. Bogdanffy, Robert F. Stachlewitz, Susan van Tongeren [...]

International Journal of Toxicology

Open access

Review article

First published 2018

Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy

Jennifer D Goldman

Clinical Medicine Insights: Endocrinology and Diabetes

Open access

Research article

First published 2016-3

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

Ian J Neeland, Darren K McGuire, Robert Chilton [...]

Diabetes & Vascular Disease Research

Free access

Research article

First published 2025

Evaluating Safety and Efficacy of Empagliflozin Alone and With Metformin in Patients With Type 2 Diabetes Mellitus: An Observational Study from Afghanistan

Mohammad Wali Naseri, Hasibullah Mohammadi, Asadullah Arsalan [...]

International Journal of Clinical Metabolism and Diabetes

Retricted access

Research article

First published 2020-10

Weight Outcomes With Empagliflozin as Compared With Liraglutide in Veterans With Type 2 Diabetes Mellitus

Ted Robert Grabarczyk, Natalie Koury Wissman

Annals of Pharmacotherapy

Open access

Research article

First published 2020-1

Effect of empagliflozin on brachial artery shear stress and endothelial function in subjects with type 2 diabetes: Results from an exploratory study

Concetta Irace, Antonio Cutruzzolà, Martina Parise [...]

Diabetes & Vascular Disease Research

Free access

Review article

First published 2015-4

Short commentary on empagliflozin and its potential clinical impact

Deborah Hinnen

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Case report

First published 2017-12

A Case of Septic Shock Due to Serratia marcescens Pyelonephritis and Bacteremia in a Patient Receiving Empagliflozin

Wesley D. Kufel, Ali Scrimenti, Jeffrey M. Steele

Journal of Pharmacy Practice

Open access

Brief report

First published 2020-11

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME ®

Gisle Langslet, Bernard Zinman, Christoph Wanner [...]

Diabetes & Vascular Disease Research

Search results